StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2021 it was -C$6.06M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2021Dec 31, 2021-C$6.06M–
FY2020Dec 31, 2020-C$728.40K–
FY2019Dec 31, 2019-C$249.58K–

More XORTX Therapeutics figures

See a number that looks wrong?